MedTrace Logo

Pharmacological Treatment In Osteoarthritis

NCT01148043 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2015-04-13

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy of hydroxychloroquine in hand osteoarthritis.

Conditions

Interventions

DRUG

Hydroxychloroquine

200 mg capsule, 2 capsules QD for 24 weeks.

DRUG

cellulose

capsule, 2 capsules QD for 24 weeks

Sponsors & Collaborators

  • Maasstad Hospital

    lead OTHER

Principal Investigators

  • Natalja M Basoski, MD · Maasstad Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2014-06-30
Completion
2014-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01148043 on ClinicalTrials.gov